# Gatx Corp: financial statements, quarterly

GATX · NYSE · CIK 40211 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gatx.md) · [Financials](/companies/gatx/financials.md) · [Filings](/companies/gatx/filings.md) · [Insiders](/companies/gatx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gatx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [360](/filings/0000040211-24-000088.md) | [369 d](/filings/0000040211-26-000018.md) | [380](/filings/0000040211-25-000045.md) | [387](/filings/0000040211-25-000085.md) | [405](/filings/0000040211-25-000118.md) | [414 d](/filings/0000040211-26-000018.md) | [422](/filings/0000040211-26-000055.md) | [431](/filings/0000040211-26-000079.md) | [439](/filings/0000040211-25-000118.md) | [449 d](/filings/0000040211-26-000018.md) | [584](/filings/0000040211-26-000055.md) | [580](/filings/0000040211-26-000079.md) |
| Selling, general and administrative | $m | [51.0](/filings/0000040211-24-000088.md) | [59.3 d](/filings/0000040211-26-000018.md) | [55.9](/filings/0000040211-25-000045.md) | [58.6](/filings/0000040211-25-000085.md) | [57.2](/filings/0000040211-25-000118.md) | [64.6 d](/filings/0000040211-26-000018.md) | [56.6](/filings/0000040211-26-000055.md) | [58.2](/filings/0000040211-26-000079.md) | [66.2](/filings/0000040211-25-000118.md) | [71.6 d](/filings/0000040211-26-000018.md) | [71.3](/filings/0000040211-26-000055.md) | [69.2](/filings/0000040211-26-000079.md) |
| Interest expense | $m | [68.1](/filings/0000040211-23-000162.md) | [72.6 d](/filings/0000040211-26-000018.md) | [77.8](/filings/0000040211-24-000039.md) | [82.8](/filings/0000040211-24-000067.md) | [88.9](/filings/0000040211-24-000088.md) | [91.5 d](/filings/0000040211-26-000018.md) | [94.9](/filings/0000040211-25-000045.md) | [96.2](/filings/0000040211-25-000085.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | [14.5](/filings/0000040211-24-000088.md) | [6.4 d](/filings/0000040211-26-000018.md) | [18.6](/filings/0000040211-25-000045.md) | [10.4](/filings/0000040211-25-000085.md) | [22.9](/filings/0000040211-25-000118.md) | [8.1 d](/filings/0000040211-26-000018.md) | [16.6](/filings/0000040211-26-000055.md) | [21.0](/filings/0000040211-26-000079.md) | [16.4](/filings/0000040211-25-000118.md) | [9.1 d](/filings/0000040211-26-000018.md) | [21.2](/filings/0000040211-26-000055.md) | [26.0](/filings/0000040211-26-000079.md) |
| Net income | $m | [52.5](/filings/0000040211-24-000088.md) | [66.0 d](/filings/0000040211-26-000018.md) | [74.3](/filings/0000040211-25-000045.md) | [44.4](/filings/0000040211-25-000085.md) | [89.0](/filings/0000040211-25-000118.md) | [76.5 d](/filings/0000040211-26-000018.md) | [78.6](/filings/0000040211-26-000055.md) | [75.5](/filings/0000040211-26-000079.md) | [82.2](/filings/0000040211-25-000118.md) | [97.0 d](/filings/0000040211-26-000018.md) | [85.5](/filings/0000040211-26-000055.md) | [103](/filings/0000040211-26-000079.md) |
| Diluted EPS | $ per share | [1.44](/filings/0000040211-24-000088.md) | not reported | [2.03](/filings/0000040211-25-000045.md) | [1.21](/filings/0000040211-25-000085.md) | [2.43](/filings/0000040211-25-000118.md) | not reported | [2.15](/filings/0000040211-26-000055.md) | [2.06](/filings/0000040211-26-000079.md) | [2.25](/filings/0000040211-25-000118.md) | not reported | [2.35](/filings/0000040211-26-000055.md) | [2.84](/filings/0000040211-26-000079.md) |
| Basic EPS | $ per share | [1.44](/filings/0000040211-24-000088.md) | not reported | [2.04](/filings/0000040211-25-000045.md) | [1.22](/filings/0000040211-25-000085.md) | [2.44](/filings/0000040211-25-000118.md) | not reported | [2.15](/filings/0000040211-26-000055.md) | [2.07](/filings/0000040211-26-000079.md) | [2.25](/filings/0000040211-25-000118.md) | not reported | [2.35](/filings/0000040211-26-000055.md) | [2.85](/filings/0000040211-26-000079.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000040211-23-000162.md) | [0.5](/filings/0000040211-25-000024.md) | [0.5](/filings/0000040211-24-000039.md) | [0.8](/filings/0000040211-24-000067.md) | [0.5](/filings/0000040211-24-000088.md) | [0.4](/filings/0000040211-26-000018.md) | [0.8](/filings/0000040211-25-000045.md) | [0.8](/filings/0000040211-25-000085.md) | [0.7](/filings/0000040211-25-000118.md) | [0.7](/filings/0000040211-26-000079.md) | [0.7](/filings/0000040211-26-000055.md) | [0.7](/filings/0000040211-26-000079.md) |
| Total assets | $bn | [10.6](/filings/0000040211-23-000162.md) | [11.3](/filings/0000040211-26-000018.md) | [11.6](/filings/0000040211-24-000039.md) | [12.2](/filings/0000040211-24-000067.md) | [12.4](/filings/0000040211-24-000088.md) | [12.3](/filings/0000040211-26-000018.md) | [13.0](/filings/0000040211-25-000045.md) | [13.2](/filings/0000040211-25-000085.md) | [13.3](/filings/0000040211-25-000118.md) | [18.0](/filings/0000040211-26-000079.md) | [17.9](/filings/0000040211-26-000055.md) | [17.7](/filings/0000040211-26-000079.md) |
| Total liabilities | $bn | [8.5](/filings/0000040211-23-000162.md) | [9.1](/filings/0000040211-25-000024.md) | [9.3](/filings/0000040211-24-000039.md) | [9.9](/filings/0000040211-24-000067.md) | [9.9](/filings/0000040211-24-000088.md) | [9.9](/filings/0000040211-26-000018.md) | [10.4](/filings/0000040211-25-000045.md) | [10.5](/filings/0000040211-25-000085.md) | [10.6](/filings/0000040211-25-000118.md) | [14.4](/filings/0000040211-26-000079.md) | [14.3](/filings/0000040211-26-000055.md) | [14.1](/filings/0000040211-26-000079.md) |
| Long-term debt | $bn | not reported | [7.5](/filings/0000040211-25-000024.md) | not reported | not reported | not reported | [8.3](/filings/0000040211-26-000018.md) | not reported | not reported | not reported | [12.5](/filings/0000040211-26-000018.md) | not reported | not reported |
| Shareholders' equity | $bn | [2.2](/filings/0000040211-24-000088.md) | [2.3](/filings/0000040211-25-000024.md) | [2.3](/filings/0000040211-25-000045.md) | [2.3](/filings/0000040211-25-000085.md) | [2.4](/filings/0000040211-25-000118.md) | [2.4](/filings/0000040211-26-000018.md) | [2.5](/filings/0000040211-25-000045.md) | [2.7](/filings/0000040211-25-000085.md) | [2.7](/filings/0000040211-25-000118.md) | [2.8](/filings/0000040211-26-000079.md) | [2.8](/filings/0000040211-26-000055.md) | [2.8](/filings/0000040211-26-000079.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [142 d](/filings/0000040211-24-000088.md) | [120 d](/filings/0000040211-26-000018.md) | [97.6](/filings/0000040211-25-000045.md) | [138 d](/filings/0000040211-25-000085.md) | [160 d](/filings/0000040211-25-000118.md) | [206 d](/filings/0000040211-26-000018.md) | [124](/filings/0000040211-26-000055.md) | [161 d](/filings/0000040211-26-000079.md) | [218 d](/filings/0000040211-25-000118.md) | [144 d](/filings/0000040211-26-000018.md) | [199](/filings/0000040211-26-000055.md) | [276 d](/filings/0000040211-26-000079.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [19.9 d](/filings/0000040211-24-000088.md) | [19.9 d](/filings/0000040211-26-000018.md) | [22.0](/filings/0000040211-25-000045.md) | [21.0 d](/filings/0000040211-25-000085.md) | [20.9 d](/filings/0000040211-25-000118.md) | [20.9 d](/filings/0000040211-26-000018.md) | [23.5](/filings/0000040211-26-000055.md) | [22.2 d](/filings/0000040211-26-000079.md) | [22.1 d](/filings/0000040211-25-000118.md) | [22.0 d](/filings/0000040211-26-000018.md) | [25.2](/filings/0000040211-26-000055.md) | [23.8 d](/filings/0000040211-26-000079.md) |
| Share repurchases | $m | [0.0 d](/filings/0000040211-24-000088.md) | [2.6 d](/filings/0000040211-26-000018.md) | [4.6](/filings/0000040211-25-000045.md) | [4.3 d](/filings/0000040211-25-000085.md) | [12.9 d](/filings/0000040211-25-000118.md) | [0.1 d](/filings/0000040211-26-000018.md) | [1.9](/filings/0000040211-26-000055.md) | [15.2](/filings/0000040211-26-000079.md) | [1.5 d](/filings/0000040211-25-000118.md) | [46.4 d](/filings/0000040211-26-000018.md) | [3.8](/filings/0000040211-26-000055.md) | [47.6](/filings/0000040211-26-000079.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [35.7](/filings/0000040211-23-000162.md) | [35.8](/filings/0000040211-24-000039.md) | [35.7](/filings/0000040211-24-000067.md) | [35.8](/filings/0000040211-24-000088.md) | [35.9](/filings/0000040211-25-000045.md) | [35.9](/filings/0000040211-25-000085.md) | [35.9](/filings/0000040211-25-000118.md) | [36.0](/filings/0000040211-26-000055.md) | [35.9](/filings/0000040211-26-000079.md) | [36.0](/filings/0000040211-25-000118.md) | [35.8](/filings/0000040211-26-000055.md) | [35.8](/filings/0000040211-26-000079.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,300,000 at 2026-06-30, from the cover of the [10-Q filed 2026-07-31](/filings/0000040211-26-000079.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.